Patent: 6,696,483
✉ Email this page to a colleague
Summary for Patent: 6,696,483
Title: | Inhibitors of angiogenesis and tumor growth for local and systemic administration |
Abstract: | The invention provides pharmaceutical formulations and methods for the treatment of individuals suffering from a condition, disease, or disorder that is treatable by the inhibition of angiogenesis. The compositions comprise a Golgi apparatus disturbing agent in a substantially nontoxic amount effective to inhibit angiogenesis in a patient in need of anti-angiogenesis therapy, a solvent, and a pharmaceutically acceptable carrier. In preferred formulations, the Golgi apparatus disturbing agent is brefeldin A. |
Inventor(s): | Singh; Saira Sayed (Los Gatos, CA) |
Assignee: | OncoPharmaceutical, Inc. (Los Gatos, CA) |
Application Number: | 09/971,062 |
Patent Claims: | see list of patent claims |
Details for Patent 6,696,483
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Recordati Rare Diseases, Inc. | ELSPAR | asparaginase | For Injection | 101063 | 01/10/1978 | ⤷ Try a Trial | 2020-10-03 |
Clinigen, Inc. | PROLEUKIN | aldesleukin | For Injection | 103293 | 05/05/1992 | ⤷ Try a Trial | 2020-10-03 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |